Conference - Cambridge, UK
Technological advances in high throughput biology, imaging, data management and tissue banking mean that there has never been greater capacity to understand the pathophysiology of numerous diseases and chronic health conditions at the molecular level.
Those same advances enable better health management in terms of disease detection and therapeutic management. With the increased capability to address such questions, it also comes greater scrutiny by regulators such as the FDA now requesting data that further validates: the mode of action, stratifies patients and that supports the case for reimbursement.
Applying these tools to the discovery, development, use and regulation of new medicines will lead us closer to the goal of truly personalised medicine.
(Courtesy of http://www.onenucleus.com/)
Wed, Sep 26, 2012 - Wed, Sep 26, 2012
The Nucleus, Chesterford Research Park, Little Chesterford. CB10 1XL
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.